Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

N
Nadwodny, Kimberly

GlaxoSmithKline plc
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Kimberly Nadwodny
Favorite
Nagarajan, Venkatraman

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Venkatraman Nagarajan
Favorite
Nagaraj, Harini

University of Massachusetts
(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation
Harini Nagaraj
Favorite
Nagarsenkar, Mangal

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Mangal Nagarsenkar
Favorite
Nagata, Masashi

Institute of Science Tokyo
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Masashi Nagata
Favorite
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Masashi Nagata
Favorite
Nagata, Takako

NT Biologics
(M1130-06-35) Maintaining Pristine Structure for High-Purity Isolates: A Combined Method for Nuclei and Mitochondria
Takako Nagata
Favorite
Naguboyina, Tejaswini

University of Mississippi
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Tejaswini Naguboyina
Favorite
Nagy, Eniko

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Eniko Nagy
Favorite
Nail, Steven

Simtra BioPharma Solutions
(M0930-01-01) Graphical Design Space for the Primary Drying Phase of Freeze Drying: Factors Affecting the Dried Product Layer Resistance
Steven Nail
Favorite
Naing, Marvin

Merck & Co., Inc.
(W1130-02-10) The Advantage and Disadvantage of In Vivo Predictive Dissolution Profiles of BCS Class II Drugs Generated by a Transfer Method and Compendial Method with Different Buffer Species
Marvin Naing
Favorite
Nair, Anil

US Food and Drug Administration
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Anil Nair
Favorite
Nair, Shrikanth

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement
Shrikanth Nair
Favorite
Najafi, Ana

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ana Najafi
Favorite
Najafian, Saeed

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Saeed Najafian
Favorite
Najafi, Ron

Emery Pharma
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Ron Najafi
Favorite
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ron Najafi
Favorite
Nakagawa, Yoshiyuki

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Yoshiyuki Nakagawa
Favorite
Nakai, Takashi

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Takashi Nakai
Favorite
Nakhla, David

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
David Nakhla
Favorite
Nakhla, Nardin

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Nardin Nakhla
Favorite
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Nardin Nakhla
Favorite
Nalajala, Navya

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Navya Nalajala
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Navya Nalajala
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Navya Nalajala
Favorite
Naldrett, Hannah

University of Michigan
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Hannah Naldrett
Favorite
Namba, Chitaka

Nagoya City University
(M0930-04-24) Role of FLVCR2 in the Intestinal Choline Uptake in the Rat Model
Chitaka Namba
Favorite
Nantz, Michael

University of Louisville
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Michael Nantz
Favorite
Nappier Cherup, William

Charles River Laboratories
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
William Nappier Cherup
Favorite
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
William Nappier Cherup
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
William Nappier Cherup
Favorite
Narala, Nagarjuna

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Nagarjuna Narala
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Nagarjuna Narala
Favorite
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Nagarjuna Narala
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Nagarjuna Narala
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Nagarjuna Narala
Favorite
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Nagarjuna Narala
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Nagarjuna Narala
Favorite
Narkhede, Rajkiran

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Rajkiran Narkhede
Favorite
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Rajkiran Narkhede
Favorite
Narula, Akshay

University of Connecticut
(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
Akshay Narula
Favorite
Narwankar, Pravin

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Pravin Narwankar
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Pravin Narwankar
Favorite
Nascimento, Andre

University of Copenhagen
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Andre Nascimento
Favorite
Nasim, Md Talat

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Md Talat Nasim
Favorite
Natarajan, Karthika

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Karthika Natarajan
Favorite
Nathani, Aakash

Florida A&M University
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Aakash Nathani
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Aakash Nathani
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Aakash Nathani
Favorite
Nayar, Rajiv

HTD Biosystems Inc.
(M1430-11-60) Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry
Rajiv Nayar
Favorite
(W1030-03-16) Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis
Rajiv Nayar
Favorite
Negash, Beth

Catalent Pharma Solutions
(M1430-10-58) Rapid Material-Sparing Approach to Address Hairline Fractures in Low Drug Load Tablets via Compaction Simulation
Beth Negash
Favorite
Neill, Sterling

Mercer University
(T1230-06-34) PEGylated Nanoparticles Conjugated with LHRH Receptor Binding Peptide for Treatment of Lung Cancer
Sterling Neill
Favorite
Nejadnik, Reza

University of Iowa
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Reza Nejadnik
Favorite
(W1130-11-61) Forced Degradation of Cell-Based Therapeutic Products Using Various Stresses and Use of Flow Imaging Microscopy for Identification of Damaged Cells and Cell Debris
Reza Nejadnik
Favorite
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Reza Nejadnik
Favorite
Nejely, Arianna

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Arianna Nejely
Favorite
Nellore, Bhanuchandar

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Bhanuchandar Nellore
Favorite
Nelson, Amy J.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Amy J. Nelson
Favorite
Nesbitt, Daniel

University of Wisconsin Madison
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Daniel Nesbitt
Favorite
Nethercott, Matthew

Kansas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Matthew Nethercott
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Matthew Nethercott
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Matthew Nethercott
Favorite
Neu, Heather

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Heather Neu
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Heather Neu
Favorite
Neupane, Yub Raj

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Yub Raj Neupane
Favorite
Neusaenger, Amy

Merck & Co., Inc.
(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition
Amy Neusaenger
Favorite
Nevelos, Jim

Rayner Surgical
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Jim Nevelos
Favorite
Neveu, Aurelien

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Aurelien Neveu
Favorite
Newman, Bryan

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Bryan Newman
Favorite
Ng, Chee Meng

NewGround Pharm Consulting LLC
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Chee Meng Ng
Favorite
Ng, Ivan

Marching Pharmaceutical Limited
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Ivan Ng
Favorite
Ngo, Albert Nguessan

Florida A & M University
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Albert Nguessan Ngo
Favorite
Ngo, Hai

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Hai Ngo
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Hai Ngo
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Hai Ngo
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Hai Ngo
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Hai Ngo
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Hai Ngo
Favorite
Ngo, Teri

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Teri Ngo
Favorite
Nguyen, Duyen

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Duyen Nguyen
Favorite
Nguyen, Hiep

Center for Innovation and Science
(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation
Hiep Nguyen
Favorite
Nguyen, Hy

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Hy Nguyen
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Hy Nguyen
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Hy Nguyen
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Hy Nguyen
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Hy Nguyen
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Hy Nguyen
Favorite
Nguyen, Ivy

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Ivy Nguyen
Favorite
Nguyen, Jessica

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Jessica Nguyen
Favorite
Nguyen, Viet

Cytiva
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Viet Nguyen
Favorite
Nickel, Nils P.

Texas Tech University Health Science Center
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Nils P. Nickel
Favorite
Nickerson, Jessica

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Jessica Nickerson
Favorite
Niederquell, Andreas

University of Applied Sciences and Arts Northwestern Switzerland
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Andreas Niederquell
Favorite
Nie, Haichen

Teva Branded Pharmaceutical Products R&D, Inc.
(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility
Haichen Nie
Favorite
Nieto, Susana

Patheon, part of Thermo Fisher Scientific
(W0930-05-27) Compaction Simulation as a Risk Mitigation Strategy for Dual Sourcing on Commercial Drug Products
Susana Nieto
Favorite
Nikopour, Aryo

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Aryo Nikopour
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Aryo Nikopour
Favorite
Ning, Xin

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Xin Ning
Favorite
Nissley, Becky

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Becky Nissley
Favorite
Niu, Mengmeng

US Food and Drug Administration
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Mengmeng Niu
Favorite
Niyangoda, Sayuri

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Sayuri Niyangoda
Favorite
Noda, Tsubura

Tokyo Medial and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Tsubura Noda
Favorite
Noel, Jean-Francois

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Jean-Francois Noel
Favorite
Nofsinger, Rebecca

Eli Lilly and Company
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Rebecca Nofsinger
Favorite
Nomoto, Yasuhiro

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Yasuhiro Nomoto
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Yasuhiro Nomoto
Favorite
Norford, Madelyn

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Madelyn Norford
Favorite
North, Jeffery

Creighton University
(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
Jeffery North
Favorite
Nounou, Malak

Hall High School
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Malak Nounou
Favorite
Nounou, Mohamed

Alexandria University
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Mohamed Nounou
Favorite
Novakovic, Jasmina

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Jasmina Novakovic
Favorite
Nurunnabi, Md

University of Texas at El Paso
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Md Nurunnabi
Favorite
Nybond, Susanna

Mercodia AB
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Susanna Nybond
Favorite
Nyholm, Karen

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Karen Nyholm
Favorite